Repligen (RGEN) EPS (Basic) (2010 - 2026)

Repligen (RGEN) has 17 years of EPS (Basic) data on file, last reported at $0.15 in Q1 2026.

• On a quarterly basis, EPS (Basic) fell 98.96% year-over-year to $0.15 in Q1 2026; TTM through Mar 2026 was $0.91, a 100.97% increase from a year earlier, with the FY2025 full-year figure at $869.47, up 217.88% from the prior year.
• EPS (Basic) for Q1 2026 stood at $0.15, down from $236.94 in the prior quarter.
• Over the last five years, EPS (Basic) for RGEN reached as high as $899.3 in Q2 2022 and fell as low as -$886.93 in Q4 2024.
• Historically, EPS (Basic) has averaged $238.46 across 5 years, with a median of $83.65 in 2023.
• Across the five-year window, EPS (Basic) jumped 165952.93% in 2022 and tumbled 1160.28% in 2024, its largest moves.
• Year by year, EPS (Basic) stood at $878.63 in 2022, then sank by 90.48% to $83.65 in 2023, then tumbled by 1160.28% to -$886.93 in 2024, then surged by 126.71% to $236.94 in 2025, then plunged by 99.94% to $0.15 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $0.15 in Q1 2026, $236.94 in Q4 2025, and $22.84 in Q3 2025.